Home Forums Melanoma Diagnosis: Stage IV PD1 and IPI Combo Trial Locations Now Enrolling

  • This topic is empty.
Viewing 7 posts - 1 through 7 (of 7 total)
  • Author
    Posts
  • #21282
    Catherine Poole
    Keymaster

    This promising combo is accruing at the following: Dana Farber, Mass General, Beth Israel, Moffitt, University of VA., UPENN, University of Indiana, Lehigh Valley Health network (PA)

    If you need contact info for any of these trials, please email me: cpoole@melanomainternational.org

    #60786
    Anonymous
    Guest

    Great news Catherine!

    If the data turns out similar to that from MSK, I can easily see a future phase III trial with this combination versus either IPI or PD-1 alone. This could very well become a new standard of care if everything continues to look good.

    Frank, how close is the University of Indiana to you?

    Jeff

    #60787
    buffcody
    Participant

    Jeff,

    Caught my name out of the corner of my eye. About a day’s drive away. I’m 8 days away plus from my two seizures now and will get the oncologist’s action summary a week from Tuesday as I continue on Keppra and Dexamethasone this week in declining amounts. My thought would be that I would be ineligible for a while for anything PD-1 until the brain met issue is resolved. It would not surprise me if a reinduction of ipi is recommended ASAP given the U. of M. protocol as I know it at this moment. Maybe hand in hand with SRS or even craniotomy, since there only seems to be one. But that was last week :?

    #60788
    Nan
    Participant

    Is this trial on clinicaltrials.gov? If so, what is the number. I have ocular melanoma and have had Ipi, so am wondering if I would qualify.

    #60789
    Catherine Poole
    Keymaster

    Try this: http://clinicaltrials.gov/show/NCT01245556

    Also, look at Jonathan’s recent post about a new agent that seems promising for ocular. Put Jonathan in the search.

    #60790
    Nan
    Participant

    Thank you, Catherine.

    #60791
    justinnv
    Participant

    http://clinicaltrials.gov/show/NCT01024231

    This study lists:

    Locations

    United States, Connecticut

    Yale University School Of Medicine Recruiting

    New Haven, Connecticut, United States, 06520

    Contact: Mario Sznol, Site 001 203-785-4796

    United States, District of Columbia

    Local Institution Not yet recruiting

    Washington, District of Columbia, United States, 20057

    Contact: Site 0005

    United States, New York

    Memorial Sloan Kettering Cancer Center Recruiting

    New York, New York, United States, 11065

    Contact: Jedd Wolchok, Site 003 646-422-4631

    United States, Pennsylvania

    Local Institution Not yet recruiting

    Pittsburgh, Pennsylvania, United States, 15213-2584

    Contact: Site 0004

Viewing 7 posts - 1 through 7 (of 7 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.